Effect of prospective audit and feedback on inpatient fluoroquinolone use and appropriateness of prescribing.

Anti-Bacterial Agents / therapeutic use Feedback Fluoroquinolones / therapeutic use Humans Inpatients

Journal

Infection control and hospital epidemiology
ISSN: 1559-6834
Titre abrégé: Infect Control Hosp Epidemiol
Pays: United States
ID NLM: 8804099

Informations de publication

Date de publication:
12 2020
Historique:
pubmed: 9 8 2020
medline: 1 9 2021
entrez: 9 8 2020
Statut: ppublish

Résumé

We report the effect of prospective audit and feedback (PAF) on inpatient fluoroquinolone (FQN) prescriptions. During the PAF period, FQN use decreased from 39.19 to 29.58 days of therapy per 1,000 patient days (P < .001) and appropriateness improved from 68% to 88% (P < .001). High-yield indications to target included noninfectious urinary tract and respiratory presentations.

Identifiants

DOI: 10.1017/ice.2020.339 PMID: 32762780
pubmed: 32762780
pii: S0899823X20003396
doi: 10.1017/ice.2020.339
doi:

Substances chimiques

Anti-Bacterial Agents 0
Fluoroquinolones 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1458-1460

Auteurs

Caitlyn M Marek (CM)

Division of Infectious Diseases, Department of Medicine, Interior Health, Kamloops, British Columbia, Canada.

Karen J Zurek (KJ)

Department of Pharmacy, Covenant Health, Edmonton, Alberta, Canada.

Owen Degenhardt (O)

Department of Pharmacy, Covenant Health, Edmonton, Alberta, Canada.

Shahileen Remtulla (S)

Department of Pharmacy, Covenant Health, Edmonton, Alberta, Canada.

Alastair S Teale (AS)

Division of Infectious Diseases, Department of Medicine, Island Health, Nanaimo, British Columbia, Canada.

Carlos Cervera (C)

Division of Infectious Diseases, Department of Medicine, University of Alberta, Edmonton, Alberta, Canada.

Holly L Hoang (HL)

Division of Infectious Diseases, Department of Medicine, University of Alberta, Edmonton, Alberta, Canada.
ORCID: 0000-0002-6521-3440

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female

Evaluation of Low-Value Services Across Major Medicare Advantage Insurers and Traditional Medicare.

Ciara Duggan, Adam L Beckman, Ishani Ganguli et al.
1.00
Humans United States Aged Cross-Sectional Studies Medicare Part C

Effectiveness of Virtual Yoga for Chronic Low Back Pain: A Randomized Clinical Trial.

Hallie Tankha, Devyn Gaskins, Amanda Shallcross et al.
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH

questionsmedicales.fr › Actions chimiques et utilisations › Actions pharmacologiques › Utilisations thérapeutiques › Anti-infectieux › Antibactériens › Effect of prospective audit and feedback on...
questionsmedicales.fr › Sciences de l'information › Analyse des systèmes › Recherche opérationnelle › Rétroaction › Effect of prospective audit and feedback on...
questionsmedicales.fr › Composés hétérocycliques › Composés hétérocycliques à cycles fusionnés › Composés hétérobicycliques › Quinoléines › Quinolinone › Fluoroquinolones › Effect of prospective audit and feedback on...
questionsmedicales.fr › Eucaryotes › Animaux › Chordés › Vertébrés › Mammifères › Eutheria › Primates › Haplorhini › Catarrhini › Hominidae › Humains › Effect of prospective audit and feedback on...
questionsmedicales.fr › Personnes › Patients › Patients hospitalisés › Effect of prospective audit and feedback on...